(1)
Marucci, M. A.; Lechner , D. W.; Tafuto , B. A. Safety Outcomes of Low Versus High Dose Imatinib Mesylate in Patients With Advanced, Metastatic, or Nonresectable Gastrointestinal Stromal Tumors: A Systematic Review. GIT 2024, 2.